![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Department of Biosciences and Medical Nutrition at NOVUM, Karolinska Institutet, Huddinge, Sweden
Known mainly for its role as a toxin sensor, the aryl hydrocarbon receptor (AhR) complex is also involved in homeostasis regulation and differentiation processes and activated by xenobiotic compounds like 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Hairy and Enhancer of Split homolog-1 (HES-1) is a key regulator not only in differentiation, but also in the cell cycle, and we show here that HES-1 is a new target gene for AhR regulation. HES-1 is up-regulated by TCDD both at protein and mRNA levels in T47D human mammary carcinoma cells. Actinomycin D experiments have shown that the AhR-mediated up-regulation of HES-1 mRNA is caused by transcriptional activation of the HES-1 gene, and we have identified a functional AhR response element (XRE) at -48/-42 in the upstream regulatory region of human HES-1. The HES-1 protein down-regulates expression of its own gene, and the HES element overlaps the XRE. Our data indicate that HES-1 and the AhR complex compete for binding to the composite HES/XRE element. Also, we have previously shown that HES-1 is down-regulated by the estrogen receptor ligand 17
-estradiol (E2). Up-regulation of HES-1 expression is correlated with suppression of cell proliferation, and the E2-mediated down-regulation of HES-1 therefore increases cell proliferation. It is known that TCDD exerts antiestrogenic action in breast tissue both in vivo and in vitro. Our observation that both the estrogen receptor and AhR signaling pathways regulate HES-1, but with opposing effects, suggests the existence of a new pathway by which AhR represses E2-signaling.
Address correspondence to: Dr. Jane Sohn Thomsen, Department of Biosciences at NOVUM, Karolinska Institutet, Halsovagen 7-9, S-14157 Huddinge, Sweden. E-mail: jane.thomsen{at}biosci.ki.se
This article has been cited by other articles:
|
|
 |
|
  E. L. Hsu, D. Yoon, H. H. Choi, F. Wang, R. T. Taylor, N. Chen, R. Zhang, and O. Hankinson A Proposed Mechanism for the Protective Effect of Dioxin against Breast Cancer Toxicol. Sci., August 1, 2007; 98(2): 436 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Antkiewicz, R. E. Peterson, and W. Heideman Blocking Expression of AHR2 and ARNT1 in Zebrafish Larvae Protects Against Cardiac Toxicity of 2,3,7,8-Tetrachlorodibenzo-p-dioxin Toxicol. Sci., November 1, 2006; 94(1): 175 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Petersen, S. Krishnan, and E. D. Hudgens The Aryl Hydrocarbon Receptor Pathway and Sexual Differentiation of Neuroendocrine Functions Endocrinology, June 1, 2006; 147(6): s33 - s42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Matthews, B. Wihlen, J. Thomsen, and J.-A. Gustafsson Aryl Hydrocarbon Receptor-Mediated Transcription: Ligand-Dependent Recruitment of Estrogen Receptor {alpha} to 2,3,7,8-Tetrachlorodibenzo- p-Dioxin-Responsive Promoters Mol. Cell. Biol., July 1, 2005; 25(13): 5317 - 5328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Marchand, C. Tomkiewicz, J.-P. Marchandeau, E. Boitier, R. Barouki, and M. Garlatti 2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Insulin-Like Growth Factor Binding Protein-1 Gene Expression and Counteracts the Negative Effect of Insulin Mol. Pharmacol., February 1, 2005; 67(2): 444 - 452. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
